Approval · Notice of Compliance 9666 · 2008
STEMGEN: Notice of Compliance 9666
Issued July 10, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9666
- Date
- July 10, 2008
- Company
- Amgen Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Authorization of ancestim drug substance validation lots for commercial use
- Therapeutic class
- Hematopoietic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STEMGEN | Not yet assigned | — |
Medicinal ingredients
- ANCESTIM 1,875 MCG per VIAL